Graciano G. P.
- Country
- Spain
- Department
- Infecciosas
Research Overview
Data & Insights
Has run more than one trial at 0 of 7 partner sites.
Specializations
Cardiovascular & Vascular Medicine
The investigator focuses on diseases including acute coronary syndrome, heart failure with reduced ejection fraction, hypertension, and atherosclerotic cardiovascular disease.
- Acute myocardial infarction
- Ischemic stroke prevention
- Major adverse cardiovascular events
- Statin therapy management
Therapeutic efforts emphasize anti‑inflammatory and antithrombotic strategies to reduce cardiovascular risk.
Hematologic Oncology
Research activities target malignancies such as acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma.
- Measurable residual disease monitoring
- Targeted kinase inhibition
- Combination chemotherapy regimens
- Allogeneic hematopoietic cell transplantation
Therapeutic focus includes precision medicine approaches and novel immunotherapies for high‑risk hematologic cancers.
Infectious & Respiratory Medicine
The investigator addresses severe infections like hospital‑acquired bacterial pneumonia, ventilator‑associated pneumonia, and acute respiratory distress syndrome caused by bacterial pathogens.
- Broad‑spectrum antibacterial agents
- Adjunctive anti‑inflammatory therapies
- Ventilation management protocols
- HIV treatment optimization
Efforts aim to improve outcomes in critically ill patients through optimized antimicrobial regimens and supportive care.
Renal & Metabolic Disorders
Key interests include immunoglobulin A nephropathy and metabolic liver disease such as metabolic associated fatty liver disease with pre‑diabetes.
- Proteinuria reduction strategies
- Lipid‑modifying therapies
- Triglyceride lowering agents
- Renal function preservation
Therapeutic work centers on slowing disease progression and addressing cardiovascular complications associated with renal and metabolic conditions.
Neurology & Neurocritical Care
Clinical focus encompasses acute cerebrovascular events such as acute ischemic stroke, high‑risk transient ischemic attack, and traumatic brain injuries including subacute moderate‑to‑severe traumatic brain injury.
- Neuroprotective agents
- Hemodynamic optimization after thrombectomy
- Management of spontaneous intracerebral hemorrhage
- Recombinant coagulation factor therapies
Research aims to enhance functional recovery and reduce secondary brain injury through targeted pharmacologic and physiological interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.